Prostaglandins and nitric oxide mediate insulin-induced vasodilation in the human forearm

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 223-229

  Van Veen, Saskia ^a   Chang, Peter C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adrenergic receptors; Diabetes; EDRF; Human; Indomethacin; Insulin; Vasodilation

Indexed keywords

BETA ADRENERGIC RECEPTOR; INDOMETACIN; INSULIN; N(G) METHYLARGININE; NITRIC OXIDE; PROPRANOLOL; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; FOREARM BLOOD FLOW; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOREARM; HUMANS; INDOMETHACIN; INSULIN; ISOPROTERENOL; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROPRANOLOL; VASCULAR RESISTANCE; VASODILATION;

EID: 0030938191     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00031-X     Document Type: Article

References (39)

1. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44:121-131.
2. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992;20:S5-S10.
3. Capaldo B, Lembo G, Napoli R, et al. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991;40:1320-1322.
4. Shamiss A, Carroll J, Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens 1992;5:26-28.
5. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992;20:S40-S48.
6. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992;19:621-627.
7. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of 'syndrome X'. Am J Hypertens 1993;6:123S-134S.
8. Stenvinkel P, Bolinder J, Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 1992;35:1042-1048.
9. Friedberg CE, Vanburen M, Bijlsma JA, Koomans HA. Insulin increases sodium reabsorption in diluting segment in humans -evidence for indirect mediation through hypokalemia. Kidney Int 1991;40:251-256.
10. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillière's Clin Endocrinol Metab 1993;7:961-987.
11. Anderson EA, Mark AL. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension (Editorial). Hypertension 1993;21:136-141.
12. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 1993;342:707-709.
13. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990;85:1844-1852.
14. Anderson EA, Hoffman P, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-2252.
15. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-2515.
16. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-1179.
17. Creager MA, Liang CS, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985;235:709-714.
18. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 1994;266:R809-R816.
19. Wasner HK, Weber S, Partke HJ, Aminihadikiashar H. Indomethacin treatment causes loss of insulin action in rats: Involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol 1994;31:175-182.
20. Freedman RR, Sabharwal SC, Desai N. Sex differences in peripheral vascular adrenergic receptors. Circ Res 1987;61:581-585.
21. Chang PC, Van Brummelen P. Calibration and variability of forearm blood flow measured by strain-gauge plethysmography. J Cardiovasc Pharmacol 1987;10:S123-S125.
22. Chang PC, Verlinde R, Bruning TA, van Brummelen P. A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm. Comput Biol Med 1988;18:157-163.
23. Zhang J, Pfaffendorf M, Zhang JS, Van Zwieten P. Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam Clin Pharmacol 1995;9:25-29.
24. Bruning TA, van Zwieten PA, Blauw GJ, Chang PC. No functional involvement of 5-hydroxytryptamine 1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed. J Cardiovasc Pharmacol 1994;24:454-461.
25. Abramson DI, Schkloven N, Margolis MN, Mirsky IA. Influence of massive doses of insulin on peripheral blood flow in man. Am J Physiol 1939;128:124-132.
26. Liang C, Doherty JU, Faillance R, et al. Insulin infusion in conscious dogs: effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 1982;69:1321-1336.
27. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992;35:873-879.
28. Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 1995;13:1015-1021.
29. Grunt M, Glaser J, Schmidhuber H, Pauschinger P, Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am J Physiol 1993;264:H1124-H1129.
30. Baudry N, Vicaut E. Role of nitric oxide in effects of tumor necrosis factor-alpha on microcirculation in rat. J Appl Physiol 1993;75:2392-2399.
31. Koller A, Sun D, Huang A, Kaley G. Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol 1994;267:H326-H332.
32. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995;114:1171-1178.
33. Robinson BF, Collier JG, Karim SM, Somers K. Effect of prostaglandins A1, A2, B1, E2 and F2 on forearm arterial bed and superficial hand veins in man. Clin Sci 1973;44:367-376.
34. Rettori V, Gimeno M, Lyson K, McCann SM. Nitric oxide mediates norepinephrine-induced prostaglandin-E(2) release from the hypothalamus. Proc Natl Acad Sci USA 1992;89:11543-11546.
35. Matsumura Y, Ozawa Y, Suzuki H, Saruta T. Synergistic action of angiotensin II on norepinephrine-induced prostaglandin release from rat glomeruli. Am J Physiol 1986;250:F811-F816.
36. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 1991;88:1230-1236.
37. Trovati M, Massucco P, Mattiello L, et al. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: A mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 1995;38:936-941.
38. Lembo G, Iaccarino G, Vecchione C, Rendina V, Parrella L, Trimarco B. Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. Circulation 1996;93:1403-1410.
39. Tveskov C, Djurhuus MS, Klitgaard NA, Egstrup K. Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta 2-adrenergic stimulation with terbutaline in healthy subjects. Chest 1994;106:1654-1659.